Robert Phipps
Director, Market Access & Reimbursement

Rob Phipps, Director of Market Access & Reimbursement

The Advantages of All-Inclusive ECG Diagnostic Testing Capabilities for Patients, Physicians, and Payers


The word is getting out! The Cardiac Insight team is proud to support our growing professional medical customer base of dedicated healthcare providers who include the Cardea SOLO™ Arrhythmia Analysis System in their diagnostic tool kit every day.  Cardiac Insight customers deserve enormous credit – they are the pioneers and innovators who have adopted Cardea SOLO’s advances in automated ECG arrhythmia detection to improve healthcare quality and people’s lives.

Read More »

Robert G. Hauser, MD, FACC, FHRS

Sally Hauser in Nice, France, 2 weeks after her stroke.

In June of 2012, the consequences of asymptomatic paroxysmal atrial fibrillation came home to me and my family in a frightening, firsthand experience. My wife, Sally, suffered an acute embolic left middle cerebral artery stroke while we were traveling in Nice, France, where I was scheduled to speak at a medical conference…


Read More »

Ann Demaree, RN, Vice President Marketing & Business Development

Ann with her father shortly after his stroke.

How My Dad’s Life Might Have Been Different With Today’s Wearable ECG Technology


I’ve spent my entire career as a team member innovating technology used by medical professionals. But, <SPOILER ALERT> – I’m not going to cast even a subtle shadow of doubt on new consumer heart wearables like the Apple® Watch or even more intriguing consumer cardiac tech that’s coming. Why put tacks in that road? I say, “Bring on the consumer health wearables!” Find the bad stuff sooner. Optimize early warning systems as bridges to our healthcare professionals. And make us want to use these tools every day.

Read More »